163eP The impact of glucose levels on the efficacy of immunotherapy in patients with metastatic non-small cell lung cancer
higher baseline Hb levels and improved survival further highlights the importance of host-related factors in determining immunotherapy outcomes.
Authors
- Yulia Dudnik
- Abed Agbarya (ORCID: https://orcid.org/0000-0002-3330-2959)
- Amichay Meirovitz (ORCID: https://orcid.org/0000-0001-7479-2926)
- Walid Shalata (ORCID: https://orcid.org/0000-0002-7570-4550)
- K. Rouvinov
- N. Maimon
- A. Yaakobson
- A.Y. Cohen
- R. Bitran
Institutions
- Ben-Gurion University of the Negev (IL)
- Soroka Medical Center (IL)
- Meir Medical Center (IL)
- Bnai Zion Medical Center (IL)
Publication Details
- Journal
- ESMO Open
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1016/j.esmoop.2026.106470
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00